Effects of different PPARγ-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis
- 1 August 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (2) , 455-464
- https://doi.org/10.1046/j.1523-1755.2002.00476.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- High glucose induces MCP-1 expression partly via tyrosine kinase–AP-1 pathway in peritoneal mesothelial cellsKidney International, 2001
- Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in ratsKidney International, 2001
- Control of Vascular Cell Proliferation and Migration by PPAR-γDiabetes Care, 2001
- Antidiabetic Drugs Present and FutureDrugs, 2000
- Advanced Glycation End Product-Induced Peroxisome Proliferator-Activated Receptor γ Gene Expression in the Cultured Mesangial CellsBiochemical and Biophysical Research Communications, 1999
- Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-βKidney International, 1999
- Activation of transcription factor NF-κB in experimental glomerulonephritis in ratsPublished by Elsevier ,1999
- Expression of Peroxisome Proliferator-Activated Receptor γ (PPARγ) in Rat Aortic Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1998
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritisKidney International, 1993